{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:43:33Z","timestamp":1791423813290,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s11926-009-0010-8","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T13:08:22Z","timestamp":1233666502000},"page":"70-76","source":"Crossref","is-referenced-by-count":35,"title":["Neonatal effects of maternal antiphospholipid syndrome"],"prefix":"10.1007","volume":"11","author":[{"given":"Angela","family":"Tincani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Biasini","family":"Rebaioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lojacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,4]]},"reference":[{"key":"10_CR1","first-page":"859","volume":"9","author":"J.P. Soulier","year":"1980","unstructured":"Soulier JP, Boffa MC: Avortments \u00e0 repetition, thromboses et anticoagulant circulant antithromboplastin. Nouv Presse Med 1980, 9:859\u2013864.","journal-title":"Nouv Presse Med"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","volume":"2","author":"E.N. Harris","year":"1983","unstructured":"Harris EN, Gharavi AE, Boey ML, et al.: Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2:1211\u20131214.","journal-title":"Lancet"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/0891693031000067278","volume":"36","author":"A. Tincani","year":"2003","unstructured":"Tincani A, Balestrieri G, Danieli E, et al.: Pregnancy complications of the antiphospholipid syndrome. Autoimmunity 2003, 36:27\u201332.","journal-title":"Autoimmunity"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(83)92141-4","volume":"1","author":"W.F. Lubbe","year":"1983","unstructured":"Lubbe WF, Butler WS, Palmer SJ, Liggins GC.: Fetal survival after prednisone suppression of maternal lupusanticoagulant. Lancet 1983, 1:1361\u20131363.","journal-title":"Lancet"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"W.A. Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309\u20131311.","journal-title":"Arthritis Rheum"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12016-007-8055-9","volume":"34","author":"P.L. Meroni","year":"2008","unstructured":"Meroni PL, Gerosa M, Raschi E, et al.: Updating on pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clinic Rev Allerg Immunol 2008, 34:332\u2013337.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0028-1082270","volume":"34","author":"A. Tincani","year":"2008","unstructured":"Tincani A, Bazzani C, Zingarelli S, Lojacono A: Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis and treatment. Semin Thromb Hemost 2008, 34:267\u2013273.","journal-title":"Semin Thromb Hemost"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"V.M. Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L, et al.: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211\u2013220.","journal-title":"J Exp Med"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G. Girardi","year":"2003","unstructured":"Girardi G, Berman J, Redecha P, et al.: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003, 112:1644\u20131654.","journal-title":"J Clin Invest"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.ajog.2006.10.879","volume":"196","author":"J.M. Shamonki","year":"2007","unstructured":"Shamonki JM, Salmon JE, Hyjek E, Baergen RN: Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 2007, 196:167.e1\u2013e5.","journal-title":"Am J Obstet Gynecol"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","volume":"28","author":"I. Cavazzana","year":"2007","unstructured":"Cavazzana I, Nebuloni M, Cetin I, et al.: Complement activation in antiphospholipid syndrome: a clue for an inflammatory process? J Autoimmun 2007, 28:160\u2013164.","journal-title":"J Autoimmun"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1073\/pnas.0607514104","volume":"104","author":"Y. Martinez de la Torre","year":"2007","unstructured":"Martinez de la Torre Y, Buracchi C, Borroni EM, et al.: Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A 2007, 104:2319\u20132324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR13","first-page":"35","volume":"2","author":"M.O. Borghi","year":"2007","unstructured":"Borghi MO, Raschi E, Scurati S, et al.: Effects of a Toll-like receptor antagonist and anti-annexin A2 antibodies on binding and activation of decidual cells by anti-beta2glycoprotein I antibodies. Clin Exp Rheumatol 2007, 2:35.","journal-title":"Clin Exp Rheumatol"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1191\/0961203304lu2001oa","volume":"13","author":"P.L. Meroni","year":"2004","unstructured":"Meroni PL, Di Simone N, Testoni C, et al.: Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004, 13:649\u2013652.","journal-title":"Lupus"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S. Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.: International Consensus Statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006, 4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","volume":"87","author":"B.T. Oshiro","year":"1996","unstructured":"Oshiro BT, Silver RM, Scott JR, et al.: Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996, 87:489\u2013493.","journal-title":"Obstet Gynecol"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.0001-6349.2004.00566.x","volume":"83","author":"A. Rasmussen","year":"2004","unstructured":"Rasmussen A, Ravn P: High frequency of congenital thrombophilia in women with pathological pregnancies? Acta Obstet Gynecol Scand 2004, 83:808\u2013817.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2006.06.008","volume":"6","author":"R.A. Asherson","year":"2006","unstructured":"Asherson RA: New subsets of the antiphospholipid syndrome in 2006: \u201cPRE-APS\u201d (probable APS) and microangiopathic antiphospholipid syndromes (\u201cMAPS\u201d). Autoimmun Rev 2006, 6:76\u201380.","journal-title":"Autoimmun Rev"},{"key":"10_CR19","first-page":"952","volume":"326","author":"D.W. Branch","year":"1992","unstructured":"Branch DW, Dudley DJ, Scott JR, Silver RM: Antiphospholipid antibodies and fetal loss. N Engl J Med 1992, 326:952.","journal-title":"N Engl J Med"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1471-0528.1987.tb03162.x","volume":"94","author":"R.A. Scott","year":"1987","unstructured":"Scott RA: Anti-cardiolipin antibodies and pre-eclampsia. Br J Obstet Gynecol 1987, 94:604\u2013605.","journal-title":"Br J Obstet Gynecol"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","volume":"9","author":"E.A. Clark","year":"2007","unstructured":"Clark EA, Silver RM, Branch DW: Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007, 9:219\u2013225.","journal-title":"Curr Rheumatol Rep"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(97)02736-X","volume":"73","author":"D. Faden","year":"1997","unstructured":"Faden D, Tincani A, Tanzi P, et al.: Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997, 73:37\u201342.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-007-0742-7","volume":"27","author":"R.A. Asherson","year":"2008","unstructured":"Asherson RA, Galarza-Maldonado C, Sanin-Blair J: The HELLP syndrome, antiphospholipid antibodies, and syndromes. Clin Rheumatol 2008, 27:1\u20134.","journal-title":"Clin Rheumatol"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","volume":"64","author":"D. Thi Thuong Le","year":"2005","unstructured":"Le Thi Thuong D, Tieuli\u00e9 N, Costedoat N, et al.: The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005, 64:273\u2013278.","journal-title":"Ann Rheum Dis"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00296-007-0386-6","volume":"28","author":"P. Tsirigotis","year":"2007","unstructured":"Tsirigotis P, Mantzios G, Pappa V, et al.: Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome. Rheumatol Int 2007, 28:171\u2013174.","journal-title":"Rheumatol Int"},{"key":"10_CR26","first-page":"131","volume":"14","author":"F. Lima","year":"1996","unstructured":"Lima F, Khamashta MA, Buchanan NM, et al.: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14:131\u2013136.","journal-title":"Clin Exp Rheumatol"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/096120339300200405","volume":"2","author":"N. Zurgil","year":"1993","unstructured":"Zurgil N, Bakimer R, Tincani A, et al.: Detection of antiphospholipid and anti-DNA antibodies and their idiotypes in newborns of mothers with anti-phospholipid syndrome and SLE. Lupus 1993, 2:233\u2013237.","journal-title":"Lupus"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/humrep\/15.5.1170","volume":"15","author":"S.B. Cohen","year":"2000","unstructured":"Cohen SB, Goldenberg M, Rabinovici J, et al.: Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome. Hum Reprod 2000, 15:1170\u20131172.","journal-title":"Hum Reprod"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-2006-939533","volume":"23","author":"M. Motta","year":"2006","unstructured":"Motta M, Chirico G, Rebaioli CB, et al.: Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Perinatol 2006, 23:247\u2013251.","journal-title":"Am J Perinatol"},{"key":"10_CR30","first-page":"365","volume":"80","author":"J.K. Pollard","year":"1992","unstructured":"Pollard JK, Scott JR, Branch DW: Outcome of children born to women treated during pregnancy for the antiphospholipid syndrome. Obstet Gynecol 1992, 80:365\u2013368.","journal-title":"Obstet Gynecol"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1515\/jpme.1997.25.2.192","volume":"25","author":"F. Botet","year":"1997","unstructured":"Botet F, Romera G, Montagut P, et al.: Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J Perinat Med 1997, 25:192\u2013196.","journal-title":"J Perinat Med"},{"key":"10_CR32","first-page":"605","volume":"16","author":"A. Ruffatti","year":"1998","unstructured":"Ruffatti A, Dalla Barba B, Del Ross T, et al.: Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. Clin Exp Rheumatol 1998, 16:605\u2013610.","journal-title":"Clin Exp Rheumatol"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/JPM.1999.025","volume":"27","author":"J.A. Brewster","year":"1999","unstructured":"Brewster JA, Shaw NJ, Farquharson RG: Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999, 27:183\u2013187.","journal-title":"J Perinat Med"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1191\/0961203302lu269oa","volume":"11","author":"A. Tincani","year":"2002","unstructured":"Tincani A, Lojacono A, Taglietti M, et al.: Pregnancy and neonatal outcome in primary antiphospholipid syndrome. Lupus 2002, 11:649.","journal-title":"Lupus"},{"key":"10_CR35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/0961203307079039","volume":"16","author":"M.C. Boffa","year":"2007","unstructured":"Boffa MC, Lachassinne E: Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007, 16:634\u2013641.","journal-title":"Lupus"},{"key":"10_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1191\/0961203302lu146rr","volume":"11","author":"T. Avcin","year":"2002","unstructured":"Avcin T, Cimaz R, Meroni PL: Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002, 11:4\u201310.","journal-title":"Lupus"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1191\/0961203304lu1089oa","volume":"13","author":"M.C. Boffa","year":"2004","unstructured":"Boffa MC, Aurousseau MH, Lachassinne E, et al.: European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004, 13:713\u2013717.","journal-title":"Lupus"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clim.2004.02.018","volume":"112","author":"M. Blank","year":"2004","unstructured":"Blank M, Shoenfeld Y: Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004, 112:190\u2013199.","journal-title":"Clin Immunol"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2005.02923.x","volume":"142","author":"J. Martinuc Porobic","year":"2005","unstructured":"Martinuc Porobic J, Avcin T, Bozic B, et al.: Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005, 142:377\u2013380.","journal-title":"Clin Exp Immunol"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1749-6632.2002.tb04242.x","volume":"966","author":"J. Chapman","year":"2002","unstructured":"Chapman J, Shoenfeld Y: Neurological and neuroendocrine cytokine inter-relationship in the antiphospholipid syndrome. Ann N Y Acad Sci 2002, 966:415\u2013424.","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","volume":"12","author":"Y. Shoenfeld","year":"2003","unstructured":"Shoenfeld Y, Nahum A, Korczyn AD, et al.: Neuronalbinding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003, 12:436\u2013442.","journal-title":"Lupus"},{"key":"10_CR42","first-page":"1725","volume":"24","author":"M. Kent","year":"1997","unstructured":"Kent M, Alvarez F, Vogt E, et al.: Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 1997, 24:1725\u20131733.","journal-title":"J Rheumatol"},{"key":"10_CR43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-008-0012-y","volume":"10","author":"E. Muscal","year":"2008","unstructured":"Muscal E, Brey RL: Neurological manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr Rheumathol Rep 2008, 10:67\u201373.","journal-title":"Curr Rheumathol Rep"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1525-1470.2003.03014.x","volume":"20","author":"J.S. Prendiville","year":"2003","unstructured":"Prendiville JS, Cabral DA, Poskitt KJ, et al.: Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol 2003, 20:60\u201367.","journal-title":"Pediatr Dermatol"},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000079820","volume":"86","author":"A.A. Zuppa","year":"2004","unstructured":"Zuppa AA, Gallini F, De Luca D, et al.: Cerebral ultrasound findings in neonatal lupus syndrome. Biol Neonate 2004, 86:230\u2013234.","journal-title":"Biol Neonate"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0887-8994(01)00344-7","volume":"26","author":"K. Inoue","year":"2002","unstructured":"Inoue K, Fukushige J, Ohno T, et al.: Central nervous system vasculopathy associated with neonatal lupus. Pediatr Neurol 2002, 26:68\u201370.","journal-title":"Pediatr Neurol"},{"key":"10_CR47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1017\/S1355617797003706","volume":"3","author":"D.L. McAllister","year":"1997","unstructured":"McAllister DL, Kaplan BJ, Edworthy SM, et al.: The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. Int Neuropsychol Soc 1997, 3:370\u2013376.","journal-title":"Int Neuropsychol Soc"},{"key":"10_CR48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archpedi.157.4.397","volume":"157","author":"G. Ross","year":"2003","unstructured":"Ross G, Sammaritano L, Nass R, Lockshin M: Effects of mothers\u2019 autoimmune diseases during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003, 157:397\u2013402.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10_CR49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1191\/0961203304lu2018oa","volume":"13","author":"F. Neri","year":"2004","unstructured":"Neri F, Chimini L, Bonomi F, et al.: Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004, 13:805\u2013811.","journal-title":"Lupus"},{"key":"10_CR50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.23311","volume":"59","author":"R. Nacinovich","year":"2008","unstructured":"Nacinovich R, Galli J, Bomba M, et al.: Neuropsycological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008, 59:345\u2013351.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0010-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0010-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0010-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T08:47:39Z","timestamp":1589532459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0010-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0010-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}